Brown Advisory’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $354K | Buy |
|
|||||
2025
Q1 | $334K | Sell |
|
|||||
2024
Q4 | $2.72M | Sell |
|
|||||
2024
Q3 | $3.06M | Sell |
|
|||||
2024
Q2 | $3.44M | Buy |
|
|||||
2024
Q1 | $4.25M | Buy |
|
|||||
2023
Q4 | $3.48M | Sell |
|
|||||
2023
Q3 | $2.92M | Buy |
|
|||||
2023
Q2 | $3.11M | Sell |
|
|||||
2023
Q1 | $33.7M | Buy |
|
|||||
2022
Q4 | $36.1M | Sell |
|
|||||
2022
Q3 | $36.4M | Sell |
|
|||||
2022
Q2 | $40.4M | Sell |
|
|||||
2022
Q1 | $79.2M | Sell |
|
|||||
2021
Q4 | $241M | Sell |
|
|||||
2021
Q3 | $284M | Sell |
|
|||||
2021
Q2 | $286M | Sell |
|
|||||
2021
Q1 | $256M | Buy |
|
|||||
2020
Q4 | $214M | Sell |
|
|||||
2020
Q3 | $195M | Sell |
|
|||||
2020
Q2 | $172M | Buy |
|
|||||
2020
Q1 | $118M | Buy |
|
|||||
2019
Q4 | $140M | Buy |
|
|||||
2019
Q3 | $121M | Buy |
|
|||||
2019
Q2 | $120M | Buy |
|
|||||
2019
Q1 | $123M | Buy |
|
|||||
2018
Q4 | $90.5M | Buy |
|
|||||
2018
Q3 | $106M | Buy |
|
|||||
2018
Q2 | $78.9M | Buy |
|
|||||
2018
Q1 | $71.1M | Buy |
|
|||||
2017
Q4 | $71.6M | Sell |
|
|||||
2017
Q3 | $73.9M | Sell |
|
|||||
2017
Q2 | $78M | Buy |
|
|||||
2017
Q1 | $67.6M | Buy |
|
|||||
2016
Q4 | $53.8M | Buy |
|
|||||
2016
Q3 | $45.2M | Buy |
|
|||||
2016
Q2 | $41.5M | Buy |
|
|||||
2016
Q1 | $37.6M | Sell |
|
|||||
2015
Q4 | $40.4M | Buy |
|
|||||
2015
Q3 | $30.8M | Buy |
|
|||||
2015
Q2 | $32.4M | Sell |
|
|||||
2015
Q1 | $40.9M | Sell |
|
|||||
2014
Q4 | $34.1M | Sell |
|
|||||
2014
Q3 | $35.1M | Sell |
|
|||||
2014
Q2 | $31.6M | Buy |
|
|||||
2014
Q1 | $33.1M | Buy |
|
|||||
2013
Q4 | $27.3M | Buy |
|
|||||
2013
Q3 | $22M | Buy |
|
|||||
2013
Q2 | $17.4M | Buy |
|